Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EBT: 2018-2024

Historic EBT for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$158.1 million.

  • Legend Biotech's EBT rose 67.68% to -$39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.5 million, marking a year-over-year increase of 35.60%. This contributed to the annual value of -$158.1 million for FY2024, which is 69.60% up from last year.
  • Per Legend Biotech's latest filing, its EBT stood at -$158.1 million for FY2024, which was up 69.60% from -$520.1 million recorded in FY2023.
  • Legend Biotech's 5-year EBT high stood at -$158.1 million for FY2024, and its period low was -$520.1 million during FY2023.
  • For the 3-year period, Legend Biotech's EBT averaged around -$374.7 million, with its median value being -$445.7 million (2022).
  • In the last 5 years, Legend Biotech's EBT crashed by 142.14% in 2020 and then surged by 69.60% in 2024.
  • Over the past 5 years, Legend Biotech's EBT (Yearly) stood at -$308.3 million in 2020, then tumbled by 32.08% to -$407.2 million in 2021, then decreased by 9.46% to -$445.7 million in 2022, then dropped by 16.69% to -$520.1 million in 2023, then skyrocketed by 69.60% to -$158.1 million in 2024.